Clinical Trials Browser

Phase 1 × Small Cell Lung Carcinoma × pegfilgrastim × Clear all

NCT02649673 2023-12-05

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

Phase 1 Terminated

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT01840579 2021-06-22

MK-3475-011

Phase 1 Completed

57 enrolled 60 charts

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma